2/1/2008

The FDA has granted tentative approval to Aurobindo Pharma Ltd. for its sumatriptan succinate tablets, a generic version of GlaxoSmithKline's acute migraine headache treatment Imitrex. Last month, Ranbaxy Laboratories Ltd. settled a separate patent infringement case with Glaxo over the drug.

Full Story:
CNNMoney

Related Summaries